Tsart MCL-25 Tablet belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). Tsart MCL-25 Tablet helps lower blood pressure, thereby reduces the chances of heart problems such as heart attack and stroke. High blood pressure is a condition in which the blood exerts increased pressure on the walls of blood vessels. Symptoms include headache, dizziness, nosebleeds, changes in vision, chest pain, weakness and dyspnea (shortness of breath). However, most of the time, the signs and symptoms of hypertension are none.
 
Tsart MCL-25 Tablet is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol. Cilnidipine acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helps blood flow smoothly. Telmisartan works by blocking the angiotensin II receptor, thereby relaxes the blood vessels and lowers the blood pressure. Metoprolol slows down the heart rate and makes it easier for the heart to pump blood throughout the body. Together, Tsart MCL-25 Tablet helps treat hypertension.
 
You are advised to take Tsart MCL-25 Tablet for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, nausea, dizziness, weakness, decreased blood pressure and slow heart rate. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Try not to stop taking it on your own, as it may cause a sudden increase the blood pressure. Consult your doctor if you are pregnant or breastfeeding. Tsart MCL-25 Tablet is not recommended for children as efficacy and safety have not been established. Tsart MCL-25 Tablet may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.

Tsart MCL-25 Tablet is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol. Tsart MCL-25 Tablet is used to treat hypertension. Cilnidipine is a calcium channel blocker that acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helps blood flow smoothly. Telmisartan is an angiotensin receptor blocker that works by blocking the angiotensin II receptor, thereby relaxes the blood vessels and lowers the blood pressure. Metoprolol is a beta-blocker that slows down the heart rate and makes it easier for the heart to pump blood throughout the body. Together, Tsart MCL-25 Tablet helps treat hypertension. Tsart MCL-25 Tablet helps lower blood pressure, thereby reduces the chances of heart problems such as heart attack and stroke.

Do not take Tsart MCL-25 Tablet if you are allergic to any of its contents. Inform your doctor if you have diabetes, circulation problems, asthma, thyroid disorder, adrenal gland tumour, heart, kidney, or liver problems; if you are on a low-salt diet or if you are taking potassium supplements. Consult your doctor if you are pregnant or breastfeeding. Tsart MCL-25 Tablet is not recommended for children as efficacy and safety have not been established. Tsart MCL-25 Tablet may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Rise slowly from lying/sitting position as Tsart MCL-25 Tablet may cause dizziness (orthostatic hypotension).

• Regular monitoring of blood pressure levels, kidney function and electrolyte levels while taking Tsart MCL-25 Tablet is advised.